📊 Evidence-Based Reference

philips intellisite pathology solution

Philips Medical Systems Nederland

Summary: The Philips IntelliSite Pathology Solution is a digital pathology device used for high-resolution whole slide imaging. It is primarily used for enhancing diagnostic accuracy and collaboration in pathology. Key evidence highlights its integration in clinical settings and its impact on diagnostic workflows.

FDA Clearance Information

Pathway 510K
Decision Date December 2, 2024
Product Code PSY
Device Class Class 2
Evidence 419 studies

The Philips IntelliSite Pathology Solution was cleared by the FDA via the 510(k) pathway on December 2, 2024. It is manufactured by Philips Medical Systems Nederland and classified as a Class 2 device under product code PSY.

What It Is

The Philips IntelliSite Pathology Solution is a digital pathology system designed for creating high-resolution digital images of pathology slides. It is intended for use in primary diagnostic settings, enabling pathologists to review and annotate digital slides for enhanced diagnostic accuracy.

Clinical Applications

Common clinical scenarios for the Philips IntelliSite Pathology Solution include its use in surgical pathology for diagnostic purposes, teleconsultation, and educational applications. It is particularly useful in settings requiring collaboration and remote access to pathology expertise.

Evidence Summary

The available literature includes 7 studies, comprising various study types such as RCTs and case series, conducted between 2022 and 2025. These studies explore the device's application in different pathology contexts, including liver and breast pathology.

Reported Outcomes

Published studies report that the Philips IntelliSite Pathology Solution enhances diagnostic accuracy and facilitates collaboration among pathologists. It has been shown to improve workflow efficiency in pathology departments and supports the integration of digital pathology in clinical practice.

Safety Profile

Reported complications include challenges in adapting to digital workflows and potential technical issues with image resolution. However, no significant adverse events related to patient safety have been documented in the available studies.

Evidence Limitations

Current evidence is limited by the heterogeneity of study designs and the relatively small sample sizes in some studies. Further research is needed to explore long-term outcomes and the impact of digital pathology on patient care across diverse clinical settings.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips IntelliSite Pathology Solution?

The device is indicated for use in digital pathology to enhance diagnostic accuracy and facilitate collaboration in clinical settings.

What outcomes have been reported in clinical studies?

Studies have reported improved diagnostic accuracy, enhanced workflow efficiency, and successful integration into clinical practice.

What complications have been reported?

Reported complications include adaptation challenges to digital workflows and potential technical issues, but no significant adverse events.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.